...
首页> 外文期刊>International Journal of Engineering Practical Research >Comparative Study of in-vitro Behavior of Tetracalcium Phosphate-based Cement: Ringer’s Solution versus Human Blood Plasma
【24h】

Comparative Study of in-vitro Behavior of Tetracalcium Phosphate-based Cement: Ringer’s Solution versus Human Blood Plasma

机译:磷酸四钙基水泥体外行为的比较研究:林格氏液与人血浆

获取原文

摘要

Apatite formation ability of an implant in a supersaturated solution has been widely used to investigate its bioactivity. However, the method may provide incomplete information, because it is determined only by solution supersaturation, irrespective of biological factors. In this study, apatite-forming ability of calcium phosphate cement (CPC) was evaluated in two different media; human blood plasma and Ringer’s solution. The CPC samples were stored in human blood plasma and Ringer’s solution for different intervals and change in phase composition, microstructure and compressive strength were investigated. The reactants could be transferred to apatite phase in both Ringer’s solution and human blood plasma but the crystallinity and size of the apatite crystals was higher for the former. Furthermore, the compressive strength of sample fourteen days after soaking in Ringer’s solution was 1.6-fold of that in human blood plasma. Overall, the in vitro tests in human blood plasma which is more similar to real conditions can produce some results different from Ringer’s solution.
机译:在过饱和溶液中植入物的磷灰石形成能力已被广泛用于研究其生物活性。但是,该方法可能会提供不完整的信息,因为它仅由溶液过饱和确定,而与生物学因素无关。在这项研究中,在两种不同的介质中评估了磷酸钙水泥(CPC)的磷灰石形成能力。人体血浆和林格氏液。将CPC样品以不同的间隔存储在人血浆和林格氏液中,并研究了相组成,微观结构和抗压强度的变化。反应物可以在林格氏溶液和人血浆中转移到磷灰石相,但对于前者,磷灰石晶体的结晶度和大小更高。此外,在林格氏液中浸泡14天后,样品的抗压强度是人体血浆中抗压强度的1.6倍。总体而言,在人体血浆中进行的体外测试与实际条件更相似,其结果可能与林格的解决方案有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号